Steve Pawsey joined NeRRe Therapeutics as Chief Medical Officer in January 2017. An anaesthetist by training, Steve has extensive experience in the global pharmaceutical and biotechnology sectors, having worked in a broad range of development and medical positions in a career spanning more than 20 years.
His leadership roles have encompassed all elements of development including responsibility for clinical and pre-clinical development, drug safety and regulatory affairs across multiple therapeutic areas. Steve’s biotechnology company experience includes senior positions at UK companies Circassia, Vernalis and Pharmagene. He began his industry career working at Upjohn Laboratories in 1994, followed by several years with Abbott Laboratories in Chicago before returning to the UK to join Roche.
He holds a medical degree from the University of London and is a Fellow of both the Faculty of Pharmaceutical Medicine and the Royal College of Anaesthetists.